Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The 21St International Conference on Progress in Vaccination Against Cancer (Pivac-22), September 26-28, 2022, Turin, Italy Publisher Pubmed



Yaghobinejad M1 ; Cavallo F2 ; Conti L2 ; Quaglino E2
Authors

Source: Frontiers in bioscience (Landmark edition) Published:2022


Abstract

The 21st international congress on Progress in Vaccination against Cancer (PIVAC-22, https://www.pivac22.it/) was held from September 26 to September 28, 2022, at the Molecular Biotechnology Center Guido Tarone in Turin, Italy. The meeting covered the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, and addressed how alterations to the microenvironment's molecular and metabolic features and the microbiota impact upon the response to immunotherapy. © 2022 The Author(s). Published by IMR Press.
Related Docs
View other Related Docs
1. Immune Landscape of Hepatocellular Carcinoma: From Dysregulation of the Immune Responses to the Potential Immunotherapies, Cell Biochemistry and Function (2024)
2. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
3. Inosine, Gut Microbiota, and Cancer Immunometabolism, American journal of physiology. Endocrinology and metabolism (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (9)
Elahe Motevaseli (2)
Other Related Docs
4. Covid-19 Vaccination Anti-Cancer Impact on the Pi3k/Akt Signaling Pathway in Mc4l2 Mice Models, Microbial Pathogenesis (2024)
5. Microbiota Alterations and Their Association With Oncogenomic Changes in Pancreatic Cancer Patients, International Journal of Molecular Sciences (2021)
6. A Review on the Role of M2 Macrophages in Bladder Cancer; Pathophysiology and Targeting, International Immunopharmacology (2019)
7. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)
8. An Update on the Effects of Probiotics on Gastrointestinal Cancers, Frontiers in Pharmacology (2021)
9. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
10. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
11. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
12. Probiotic Intervention Alters Immune Gene Expression and Tumor Characteristics in Experimental Breast Cancer, Molecular Biology Reports (2025)
13. Immunotherapeutic Efficacy of a Lactobacillus Caseilysate As an Adjuvant Combined With a Heated-4T1mammary Carcinoma Cell Lysate in a Murine Model Ofbreast Cancer, Asian Biomedicine (2016)
14. The Role of Probiotics in Cancer Treatment: Emphasis on Their in Vivo and in Vitro Anti-Metastatic Effects, International Journal of Molecular and Cellular Medicine (2017)
15. Don't Eat Me/Eat Me Signals As a Novel Strategy in Cancer Immunotherapy, Heliyon (2023)
16. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
17. Prophylactic Dna Vaccine Targeting Foxp3+ Regulatory T Cells Depletes Myeloid-Derived Suppressor Cells and Improves Anti-Melanoma Immune Responses in a Murine Model, Cancer Immunology# Immunotherapy (2018)
18. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
19. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
20. Immunomodulatory Effects of Lactobacillus Strains: Emphasis on Their Effects on Cancer Cells, Immunotherapy (2015)